Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of the Effects of Ketamine on a Veteran Clinical Population With Major Depressive Disorder (MDD)

NCT03053830 is registered in ClinicalTrials.gov with VA Connecticut Healthcare System as lead sponsor.

NCT NCT03053830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03053830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of the Effects of Ketamine on a Veteran Clinical Population With Major Depressive Disorder (MDD)
Lead sponsor
VA Connecticut Healthcare System
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2017
Completion date
September 26, 2018
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder